{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:04:28Z","timestamp":1777572268161,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.imbio.2023.152748","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:43:03Z","timestamp":1694752983000},"page":"152748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality"],"prefix":"10.1016","volume":"229","author":[{"given":"Melayne Rocha","family":"Aciole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Prado","family":"Gon\u00e7ales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Areias Feitosa","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia Regina Pedrosa","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Iglis","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa Ramos Lacerda","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reginaldo Gon\u00e7alves","family":"de Lima Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edbia Cristina Rocha Vilela","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Sergio Ramos","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Maria Barros","family":"de Lorena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2023.152748_b0005","article-title":"The role of TNFR2+ Tregs in COVID-19: An overview and a potential therapeutic strategy","volume":"286","author":"AHMAD, Suhana,","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.imbio.2023.152748_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-021-03547-z","article-title":"Comparison of host endothelial, epithelial and inflammatory response in ICU patients with and without COVID-19: a prospective observational cohort study","volume":"25","author":"Bhatraju","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.imbio.2023.152748_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/371854","article-title":"Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy","volume":"2013","author":"Bremer, e.","year":"2013","journal-title":"ISRN Oncol."},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/eri.10.42","article-title":"Pneumocystis infection in humans: diagnosis and treatment","volume":"8","author":"Calder\u00f3n","year":"2010","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"5","key":"10.1016\/j.imbio.2023.152748_b0025","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen, g.","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.imbio.2023.152748_b0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","article-title":"Tumor necrosis factors","volume":"328","author":"Chu, w.","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imbio.2023.152748_b0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine stormin COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor syste","volume":"53","author":"Coperchini, f.","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.imbio.2023.152748_b0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri2526","article-title":"The role of TNF superfamily members in T-cell function and diseases","volume":"9","author":"CROFT, Michael.","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2023.152748_b0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.12788\/jhm.3560","article-title":"Early and Significant Reduction in C-Reactive Protein Levels After Corticosteroid Therapy Is Associated with Reduced Mortality in Patients With COVID-19","volume":"16","author":"Cui","year":"2021","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.imbio.2023.152748_b0050","article-title":"Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study","volume":"149","author":"FERRANDO, Elena Sancho,","year":"2022","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.imbio.2023.152748_b0060","doi-asserted-by":"crossref","first-page":"11245","DOI":"10.18632\/aging.103372","article-title":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study","volume":"12","author":"HAN, Yi,","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0065","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1590\/1806-9282.66.6.842","article-title":"HAYIRO\u011eLU, Mert \u0130lker; \u00c7INAR, Tufan; TEKKE\u015eIN, Ahmet \u0130lker. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19","volume":"66","author":"Hay\u0131ro\u011flu","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"7","key":"10.1016\/j.imbio.2023.152748_b0070","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"HENRY, Brandon Michael,","year":"2020","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"1","key":"10.1016\/j.imbio.2023.152748_b0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"issue":"10223","key":"10.1016\/j.imbio.2023.152748_b0080","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imbio.2023.152748_b0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imbio.2023.152748_b0095","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"LIU, Jing,","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.imbio.2023.152748_b0100","unstructured":"LUCAS, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature, v. 584, n. June 2020."},{"issue":"3","key":"10.1016\/j.imbio.2023.152748_b0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik","year":"2021","journal-title":"BMJ Evid.-based Med."},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the Inflammatory Response to Severe COVID-19 Illness","volume":"202","author":"McElvaney","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10229","key":"10.1016\/j.imbio.2023.152748_b0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta, p.","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.imbio.2023.152748_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00033-18","article-title":"Lactic acid downregulates viral microRNA to promote Epstein-Barr Virus-immortalized B lymphoblastic cell adhesion and growth","volume":"92","author":"Mo","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2023.152748_b0130","doi-asserted-by":"crossref","unstructured":"MORTAZ, Esmaeil et al. Increased serum levels of soluble TNF-\u03b1 receptor is associated with ICU mortality in COVID-19 patients.Front. Immunol., v. 12, 2021.","DOI":"10.3389\/fimmu.2021.592727"},{"issue":"16","key":"10.1016\/j.imbio.2023.152748_b0135","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.3390\/ijms22168423","article-title":"Severe COVID-19 patients show an increase in soluble TNFR1 and ADAM17, with a relationship to mortality","volume":"22","author":"Palacios","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers associated with COVID-19 disease progression","volume":"57","author":"Ponti","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.imbio.2023.152748_b0150","doi-asserted-by":"crossref","unstructured":"QIN, C. et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, v. 71, n. 15, p. 762\u2013768, 2020.","DOI":"10.1093\/cid\/ciaa248"},{"issue":"12","key":"10.1016\/j.imbio.2023.152748_b0160","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S2213-2600(20)30366-0","article-title":"Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study","volume":"8","author":"SINHA, Pratik,","year":"2020","journal-title":"The Lancet Respir. Med."},{"key":"10.1016\/j.imbio.2023.152748_b0165","article-title":"Treatment for COVID-19: An overview","volume":"889","author":"STASI, Cristina,","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.imbio.2023.152748_b0170","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor \u03b1 in vitro and in vivo","volume":"89","author":"van Zee","year":"1992","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0175","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures","volume":"92","author":"Wang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imbio.2023.152748_b0180","unstructured":"WHO. Coronavirus diseade (COVID-19) pandemic. Dispon\u00edvel em: <https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019>. Accessed in: 27 mar. 2023."},{"issue":"6","key":"10.1016\/j.imbio.2023.152748_b0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019\u2019 in COVID-19\u2019","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"issue":"7798","key":"10.1016\/j.imbio.2023.152748_b0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou, p.","year":"2020","journal-title":"Nature"},{"issue":"6508","key":"10.1016\/j.imbio.2023.152748_b0055","doi-asserted-by":"crossref","first-page":"1203.12","DOI":"10.1126\/science.369.6508.1203-l","article-title":"Immune profiling of COVID-19 patients","volume":"369","author":"Funk","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.imbio.2023.152748_b0085","doi-asserted-by":"crossref","unstructured":"LEE, Ing\u2010Kit et al. 2009 pandemic influenza A (H1N1): clinical and laboratory characteristics in pediatric and adult patients and in patients with pulmonary involvement.Influenza and other respiratory viruses, v. 6, n. 6, p. e152-e161, 2012.","DOI":"10.1111\/j.1750-2659.2012.00410.x"},{"issue":"1","key":"10.1016\/j.imbio.2023.152748_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","article-title":"Cytokine Storms: Understanding COVID-19","volume":"53","author":"Mangalmurti","year":"2020","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.imbio.2023.152748_b0140","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: A storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.imbio.2023.152748_b0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523045503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523045503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:52:05Z","timestamp":1759251125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523045503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0171298523045503"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152748","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of soluble TNF receptors (sTNFR1 and sTNFR2) increase with clinical worsening of patients and are related to COVID-19 mortality","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152748"}}